Real-World Experience With Lenacapavir and/or Fostemsavir as Emerging Therapies for the Management of Multidrug-Resistant HIV-1 in Southeastern France.

Yeztugo (lenacapavir) - Gilead

Vocabria (cabotegravir oral) - ViiV Healthcare

Rukobia (fostemsavir extended release) - ViiV Healthcare

http://www.ncbi.nlm.nih.gov/pubmed/42725571

Amelie Menard; Caroline Solas; Céline Boschi; Christelle Tomei; Hugo Bes-Barlandier; Isabelle Ravaux; Matthieu Million; Nadège Néant; Philippe Colson; Saadia Mokhtari; Syrine Boujamline; Yacine Belkhir

Sep 12, 2026